Company Analysis
Sign in

Anavex Life Sciences Corp. (AVXL)

Nasdaq: AVXL · Biological Products, (No Diagnostic Substances) · New York, NY · filing with the SEC since 2005
Full chart Alerts Compare
Grade5.9
◀ Past 5.1● Present 5.8▶ Future 6.6
6 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Income statement, as filed

In US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in September.
Income statement, by fiscal year, newest first
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period endingSep 30, 2025Sep 30, 2024Sep 30, 2023Sep 30, 2022Sep 30, 2021Sep 30, 2020Sep 30, 2019Sep 30, 2018Sep 30, 2017Sep 30, 2016
Report filedNov 25, 2025Dec 23, 2024Nov 27, 2023Nov 28, 2022Nov 24, 2021Dec 28, 2020Dec 16, 2019Dec 12, 2018Dec 11, 2017·
For lenders
Net interest income4,678,0007,320,0006,519,000947,000r26,000r179,973207,280255,09288,09811,322
Research and development37,592,00041,838,00043,717,00037,916,000r32,984,000r25,231,62322,260,34913,344,42110,672,0867,254,303
Selling, general and administrative13,816,00011,039,00012,046,000·······
General and administrative13,816,00011,039,00012,046,000r13,070,000r9,018,000r5,856,6096,846,5995,989,1705,008,2758,334,740
Total operating expenses51,408,00052,877,00055,763,000r50,986,000r42,002,000r-31,088,232r29,106,94819,333,59115,680,36115,589,043
Operating income-51,408,000-52,877,000-55,763,000r-50,986,000r-42,002,000r-31,088,232····
Total non-operating income (expense)5,031,0009,875,0008,258,0003,366,000r4,361,000r4,830,4262,894,1502,153,601r2,279,563881,960
Income before income taxes-46,377,000-43,002,000-47,498,000-47,620,000r-37,641,000r-26,257,806-26,212,798-17,179,990r-13,400,798-14,707,083
Net income-46,377,000-43,002,000-47,505,000-47,978,000r-37,909,000r-26,280,470-26,294,979-17,252,736r-13,460,405-14,736,698
Earnings per share, basic-0.54-0.52-0.60-0.62-0.54····-0.42
Earnings per share, diluted-0.54-0.52-0.60-0.62-0.54····-0.42
Earnings per share, basic and diluted····-0.54-0.45-0.54-0.39-0.33-0.42
Weighted average shares, basic85,289,44783,468,04979,787,59676,909,99369,802,960····35,153,426
Weighted average shares, diluted85,289,44783,468,04979,787,59676,909,99369,802,960····35,153,426
Weighted average shares, basic and diluted····69,802,96058,194,89448,906,47044,655,72540,841,03335,153,426
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Net interest income interest earned less interest paidus-gaap:InterestIncomeExpenseNet
Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative the cost of selling and of running the companyus-gaap:SellingGeneralAndAdministrativeExpense
General and administrative the cost of running the company itselfus-gaap:GeneralAndAdministrativeExpense
Total operating expenses the running costs togetherus-gaap:OperatingExpenses
Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss
Total non-operating income (expense) everything outside the business, togetherus-gaap:NonoperatingIncomeExpense
Income before income taxes profit before taxus-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss
Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic
Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted
Earnings per share, basic and diluted net income per share, where both counts are the sameus-gaap:EarningsPerShareBasicAndDiluted
Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic
Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Weighted average shares, basic and diluted the average count, where both counts are the sameus-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
SI Assistanton AVXL · research, not advice